About the clinic
Healthy Longevity Clinic brings together physicians, advanced diagnostics and the Longevitytech.fund ecosystem to help you protect your health, vitality and independence. Our clinics in Prague and South Florida connect emerging science with personal care and measurable follow-through.
Staying active, thinking clearly and having energy for the people and work you value are personal goals. We look at the whole person: medical history, organ-system health, physical function, sleep, nutrition and daily life. Together, these guide an individual plan to address risks and support long-term health.
Our people
Our global team leads HLC’s medical, scientific and organizational work across locations. For the people associated with your clinic, visit Locations.
CEO
Our global team
Petr has been a serial tech entrepreneur for more than 36 years.
Petr has been a serial tech entrepreneur for more than 36 years. He is building the science, funding and business infrastructure to support faster adoption of technologies that improve healthspan.
He is a founder of Longevitytech.fund, a venture capital fund with 35 longevity portfolio companies, and a former Entrepreneur in Residence at Singularity University. He is CEO of HealthyLongevity.cafe and a board member of Klothea Bio and Animal Biosciences in the United States.
Co-founder and CEO, Prague clinic
Our global team
Sees clients in Prague
František Zámola, MD, is a physician, co-founder and CEO of Healthy Longevity Clinic in Prague.
František Zámola, MD, is a physician, co-founder and CEO of Healthy Longevity Clinic in Prague. For more than 30 years, his work has connected medicine, elite sport, nutrition and the optimisation of physical and mental performance.
His current practice focuses on preventive and personalised medicine, healthy ageing and longevity. He combines clinical examination with modern laboratory diagnostics, genetics, epigenetics, imaging and the assessment of metabolism, hormonal health, body composition, cardiovascular risk and biological age. His aim is to translate new scientific findings into practical, sustainable programmes for the clinic's clients.
He also has a longstanding interest in sports medicine, nutritional, sports and pharmacogenetics, and individually guided supplementation. His experience spans elite sport, clinical medicine, international pharmaceutical companies and genetic laboratories. He has also worked with companies focused on DNA analysis, telomere biology and personalised prevention.
He graduated from Charles University and the Military Medical Academy in Hradec Králové. His medical experience includes oncology and the Department of Clinical Biochemistry and Diagnostics at University Hospital Hradec Králové, and internal medicine at the Military Hospital in Bratislava. He also studied at the Faculty of Physical Education and Sport, Charles University, completing comprehensive coaching education and training in sports medicine.
He speaks Czech, Slovak, Hungarian and English, and can also communicate in German and Russian. He is a member of the Czech Society of Sports Medicine and the American Academy of Anti-Aging Medicine.
Chief Medical Officer
Our global team
Dr Ana Baroni holds degrees in Medicine and Journalism, as well as a doctorate in Molecular Diagnosis.
Dr Ana Baroni holds degrees in Medicine and Journalism, as well as a doctorate in Molecular Diagnosis. With 20+ years of experience in consulting for longevity, regenerative, functional, integrative, and precision medicine, she is well-equipped to consider the whole picture and stay updated on innovative technology related to health. She is a Professor at Barcelona University in its Master in Longevity program. She sits on scientific advisory boards for longevity and biotech companies in the US, EU, and Middle East. She has completed a postdoctoral program in Family Medicine, as well as a four-year residency in Occupational Medicine. Dr. Baroni has undergone executive education programs such as Business Strategy and Financial Performance from INSEAD, Competitive Advantage from Wharton, and Disruptive Innovation from Harvard.
Chief Executive Officer, US
Our global team
Sees clients in Boca Raton · Miami
Dr. Uberto L.
Dr. Uberto L. Mondolfi is the Chief Executive Officer of Healthy Longevity Clinic (HLC) USA, where he leads the development of an integrated approach to longevity medicine centered on prevention, personalized care, and long-term health optimization.
With more than two decades of experience in psychological wellness and behavioral health, Dr. Mondolfi brings a multidisciplinary perspective to healthcare leadership. He holds a PhD in Advanced Counseling Studies and Psychological Addictions, with a focus on the complex relationship between human behavior, emotional wellbeing, addiction, and recovery. His academic background also includes Civil Engineering and Business Administration, giving him a distinctive combination of clinical, analytical, and strategic expertise.
Throughout his career, Dr. Mondolfi has focused on the connection between mental, physical, and emotional health and the role each plays in long-term wellbeing. At HLC, he brings this perspective into a broader model of physician-guided longevity care, integrating advanced diagnostics, emerging health technologies, behavioral insights, and evidence-informed lifestyle strategies to help individuals better understand and actively manage how they age.
Under his leadership, HLC is advancing a more integrated and personalized approach to healthspan, connecting science and technology with human-centered care to support healthier, more resilient lives over time.
Director of Bioinformatics
Our global team
Raghav is pursuing doctoral research at Yale University under the mentorship of Dr. Albert Higgins-Chen and Dr. Morgan Levine.
Raghav is pursuing doctoral research at Yale University under the mentorship of Dr. Albert Higgins-Chen and Dr. Morgan Levine. With over a decade of expertise in Computational Biomedical technologies, Raghav specializes in integrating Data Science and Artificial Intelligence into the biomedical domain. His notable achievement was the development of Systems Age, a patented DNA methylation biomarker. Currently, in his role as Director of Bioinformatics at Healthy Longevity Clinic, Raghav leverages his expertise in aging interventions and biomarkers, coupled with machine learning methodologies, to develop tools for personalized mapping of aging interventions based on individual biomarkers and treatment responses.
Founder story
Founded in 2021, HLC grew from a conviction that advances in longevity science should become useful in people’s lives. Co-founder and CEO Petr Sramek is also a co-founder and managing partner of Longevitytech.fund. That connection places our clinical work in direct contact with the scientists and companies developing the next generation of longevity technologies.
Petr Sramek, MBA · CEO
Relationships with portfolio founders, researchers and technology teams give HLC early visibility into promising science. Our clinical facilities, medical teams and measurement capabilities help turn selected research questions into human data. What we learn can inform future studies, monitoring and clinical protocols. For clients, this means care with a direct view of the field’s development and physicians who can interpret what matters.
Clinical laboratory testing, body composition, functional assessment and biological-age measures contribute different perspectives. We connect the relevant findings through organ-system analysis and physician interpretation, so your next step follows from a coherent view of your health.
Our medical, nutrition, movement and psychology expertise supports a multimodal approach. Assessment leads to priorities; your physician helps select the appropriate combination of care, lifestyle changes and follow-up. Your plan is designed around your needs and the life you lead.
HLC combines clinical delivery with the structured evaluation of longevity approaches. Our XPRIZE Healthspan proof-of-concept study is one example of this work. Repeated clinical, biological and functional measurements help us examine change, understand limitations and improve the next research question.
A useful plan needs follow-through. From a focused Healthy Longevity Plan to a broader assessment or an ongoing care relationship, we connect physician guidance with coordination and planned reviews. Prague and South Florida offer complementary settings for clients who live locally or divide their time between countries.
Our relationship with Longevitytech.fund connects a global network of scientists and biotechnology companies with HLC’s clinical teams, diagnostics and ongoing care. It gives us a practical role in learning how promising science translates into people’s lives.
Longevitytech.fund’s portfolio and wider scientific network bring sustained contact with founders, researchers and emerging platforms. HLC can discuss the underlying mechanisms, the available evidence and the questions still to be answered directly with the teams developing them. This informs the selection of research opportunities and our understanding of the field.
HLC contributes clinical facilities, medical expertise, participant coordination and longitudinal follow-up to selected research work, including carefully designed first-in-human evaluation. A defined question is paired with the applicable research pathway, appropriate participants, responsible professionals and a measurement plan. This is how scientific access can become useful human evidence.
Clinical laboratory results, biological-age platforms, organ-system analysis and functional tests can examine different aspects of a response. Looking across these measures helps the team assess positive findings alongside unchanged, unfavorable or uncertain results.
Findings feed back to researchers and clinical teams. They can refine monitoring, participant selection, follow-up and future protocol design. Prague provides an advanced clinical and translation base, while Miami supports private-client care and HLC’s U.S. innovation platform; Boca Raton contributes consultation and continuity care.
You gain a clinical relationship informed by direct scientific dialogue, careful measurement and a view of where longevity medicine is heading. Your physician translates that perspective into advice appropriate to your health. Participation in research follows a separate assessment, consent and oversight process; clinical recommendations are guided by evidence and individual suitability.
Direct relationships with scientists and Longevitytech.fund portfolio teams.
Medical teams, a defined research question and an appropriate human evaluation pathway.
Clinical, biological and functional findings examined over time.
Better evidence for research, monitoring and future clinical protocols.
“Findings return to researchers and physicians to inform the next question and the next step.”
Research opportunities follow their own suitability assessment, informed consent and oversight.
